Detection of multiple antibodies in myasthenia gravis and its clinical significance

Chinese Medical Journal

Volumn 123, Issue 18, 2010, Pages 2555-2558

  Wang, Wei Wei ^a   Hao, Hong Jun ^b   Gao, Feng ^b  

^a Jishuitan Orthopaedic College of Tsinghua University   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Antibody; Myasthenia gravis; Thymoma

Indexed keywords

ACETYLCHOLINESTERASE ANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; ENZYME ANTIBODY; NEOSTIGMINE; PROTEIN ANTIBODY; RYANODINE RECEPTOR ANTIBODY; TITIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; ONSET AGE; SENSITIVITY AND SPECIFICITY; THYMOMA;

ADULT; AGE OF ONSET; ANTIBODIES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; THYMOMA;

EID: 79851477224     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.18.011     Document Type: Article

References (21)

1. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 1975; 51: 933-939.
2. Meriggioli MN. Myasthenia gravis with anti acetylcholine receptor antibodies. Front Neurol Neurosci 2009; 26: 94-108.
3. Lindstrom JM. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert Eaton syndrome. Annu Rev Immunol 1985; 3: 109-131.
4. Li Z, Forester N, Vincent A. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non acetylcholine receptor ligands: possible relevance to seronegative myasthenia gravis. J Neuroimmunol 1996; 64: 179-183.
5. Aarli JA, Stefansson K, Marton LS, Wollmann R. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibidies against titin. Clin Exp Immunol 1990; 82: 284-288.
6. Mygland A, Tysnes OB, Matre R, Volpe P, Aarli JA, Gilhus NE. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol 1992; 32: 589-591.
7. Tang J, Yuan J, Hao H. Anti acetylcholinesterase antibody in myasthenic syndrome. Chin Med J 1997; 110: 698-700.
8. Ying ZL, Zhou JF, Zhang YD. Determination of activity of blood acetylcholinesterase in mya sthenia gravis patients and its clinical significance. J Clin Neurol (Chin) 1998; 11: 10-12.
9. Lübke E, Freiburg A, Skeie GO, Kdmerer B, Labeits, Aarli JA, et al. Striational autoantibodies in myasthenia gravis patients recognize Iband titin epitopes. J Neuroimmunol 1998; 81: 98-108.
10. Labeit S, Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 1995; 270: 293-296.
11. Skeie GO, Aarli JA, Gilhus NE. Titin and ryanodine receptor antibody in myasthenia gravis. Acta Neurol Scand Suppl 2006; 183: 19-23.
12. Inui M, Saito A, Fleischer S. Isolation of the ryanodine receptor from cardiac sarcoplasmic reticulum and identity with the feet structures. J Biol Chem 1987; 262: 15637-15642.
13. Takeshima H, Lino M, Takekura H, Nishi M, Kuno J, Minowa O, et al. Excitation contraction uncoupling in mice lacking functional skeletal muscle ryanodine receptor gene. Nature 1994; 369: 556-559.
14. Romi F, Skeie GO, Aarli JA, Gilhus NE. Muscle autoantibodies in subgroups of myasthenia gravis patients. J Neurol 2000; 247: 369-375.
15. Romi F, Aarli JA, Gilhus NE. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. Eur J Neurol 2007; 14: 617-620.
16. Romi F, Skeie GO, Gilhus NE, Aarli JA. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 2005; 62: 442-446.
17. Romi F, Bo L, Skeie GO, Myking A, Aarli JA, Gilhus NE. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 2002; 128: 82-89.
18. Nicolaou S, Müller NL, Li DK, Oger JJ. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy. Radiology 1996; 201: 471-474.
19. Romi F, Skeie GO, Aarli JA, Gilhus NE. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor. Arch Neurol 2000; 57: 1596-1600.
20. Skeie GO, Romi F. Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol 2008; 15: 1029-1033.
21. Aarli JA. Myasthenia Gravis in the Elderly Is It Different? Ann N Y Acad Sci 2008; 1132: 238-243.